Pages

Wednesday, May 13, 2020

MasterPharm, LLC. Issues Voluntary Nationwide Recall of Finasteride Plus 1.25mg Due to the Presence of an Undeclared Antihypertensive Drug May 11, 2020


https://www.drugs.com/fda/masterpharm-llc-issues-voluntary-nationwide-recall-finasteride-plus-1-25mg-due-presence-undeclared-14369.html?utm_source=ddc&utm_medium=rss&utm_campaign=MasterPharm%2C+LLC.+Issues+Voluntary+Nationwide+Recall+of+Finasteride+Plus+1.25mg+Due+to+the+Presence+of+an+Undeclared+Antihypertensive+Drug

No comments:

Post a Comment